CASBF
Price
$6.60
Change
+$0.62 (+10.37%)
Updated
Sep 17 closing price
Capitalization
2.12B
CRLBF
Price
$1.32
Change
-$0.04 (-2.94%)
Updated
Sep 30 closing price
Capitalization
464.26M
37 days until earnings call
Interact to see
Advertisement

CASBF vs CRLBF

Header iconCASBF vs CRLBF Comparison
Open Charts CASBF vs CRLBFBanner chart's image
CANSINO BIOLOGICS
Price$6.60
Change+$0.62 (+10.37%)
Volume$115
Capitalization2.12B
Cresco Labs
Price$1.32
Change-$0.04 (-2.94%)
Volume$1.32M
Capitalization464.26M
CASBF vs CRLBF Comparison Chart in %
Loading...
CASBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CASBF vs. CRLBF commentary
Oct 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CASBF is a Buy and CRLBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 01, 2025
Stock price -- (CASBF: $6.60 vs. CRLBF: $1.36)
Brand notoriety: CASBF and CRLBF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CASBF: 68% vs. CRLBF: 269%
Market capitalization -- CASBF: $2.12B vs. CRLBF: $464.26M
CASBF [@Pharmaceuticals: Generic] is valued at $2.12B. CRLBF’s [@Pharmaceuticals: Generic] market capitalization is $464.26M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CASBF’s FA Score shows that 1 FA rating(s) are green whileCRLBF’s FA Score has 0 green FA rating(s).

  • CASBF’s FA Score: 1 green, 4 red.
  • CRLBF’s FA Score: 0 green, 5 red.
According to our system of comparison, CASBF is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CASBF’s TA Score shows that 2 TA indicator(s) are bullish while CRLBF’s TA Score has 6 bullish TA indicator(s).

  • CASBF’s TA Score: 2 bullish, 3 bearish.
  • CRLBF’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, CRLBF is a better buy in the short-term than CASBF.

Price Growth

CASBF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while CRLBF (@Pharmaceuticals: Generic) price change was +22.52% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.69%. For the same industry, the average monthly price growth was +45.06%, and the average quarterly price growth was +96.58%.

Reported Earning Dates

CRLBF is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.69% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CASBF($2.12B) has a higher market cap than CRLBF($464M). CASBF YTD gains are higher at: 64.959 vs. CRLBF (48.840). CRLBF has higher annual earnings (EBITDA): 136M vs. CASBF (-1.88B). CASBF has more cash in the bank: 4.02B vs. CRLBF (147M). CRLBF has less debt than CASBF: CRLBF (631M) vs CASBF (2.12B). CRLBF has higher revenues than CASBF: CRLBF (685M) vs CASBF (359M).
CASBFCRLBFCASBF / CRLBF
Capitalization2.12B464M458%
EBITDA-1.88B136M-1,385%
Gain YTD64.95948.840133%
P/E RatioN/AN/A-
Revenue359M685M52%
Total Cash4.02B147M2,731%
Total Debt2.12B631M336%
FUNDAMENTALS RATINGS
CRLBF: Fundamental Ratings
CRLBF
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CASBFCRLBF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
54%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CASBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MWOHX63.89N/A
N/A
MFS Global Growth R3
MITEX17.39N/A
N/A
Matthews Asia Innovators Institutional
TIBGX31.80N/A
N/A
Thornburg Investment Income Builder R4
CENNX13.83N/A
N/A
Centerstone Investors C
CSPYX21.89N/A
N/A
Columbia Small Cap Index Inst3

CASBF and

Correlation & Price change

A.I.dvisor tells us that CASBF and CRLBF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CASBF and CRLBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CASBF
1D Price
Change %
CASBF100%
N/A
CRLBF - CASBF
3%
Poorly correlated
+32.04%
CNTMF - CASBF
2%
Poorly correlated
+11.70%
BUDZ - CASBF
2%
Poorly correlated
+14.10%
CBWTF - CASBF
1%
Poorly correlated
+3.81%
CPHRF - CASBF
0%
Poorly correlated
N/A
More

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TSNDF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+32.04%
TSNDF - CRLBF
76%
Closely correlated
+27.76%
CURLF - CRLBF
76%
Closely correlated
+37.02%
TCNNF - CRLBF
75%
Closely correlated
+21.25%
JUSHF - CRLBF
74%
Closely correlated
+25.78%
VRNOF - CRLBF
73%
Closely correlated
+28.95%
More